McN3716
CAS No. 69207-52-9
McN3716 ( Methyl palmoxirate | NSC359682 )
产品货号. M21897 CAS No. 69207-52-9
McN3716 是一种肉碱棕榈酰转移酶 I (CPT-1) 抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥7857 | 有现货 |
|
50MG | ¥16038 | 有现货 |
|
100MG | ¥20250 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称McN3716
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述McN3716 是一种肉碱棕榈酰转移酶 I (CPT-1) 抑制剂。
-
产品描述Inhibition of brain mitochondrial β-oxidation by McN3716 (Methyl palmoxirate, MEP) significantly reduces the levels of all measured HETE and epoxytrienoic acids (EET), nonenzymatic auto-oxidative metabolites of ARA, by 23% to 44% and 32% to 50% compared with vehicle-injected rats, respectively, except for 15-HETE which was unaffected. There is a significant 34% reduction in the level of 6-keto-PGF1α, a byproduct of PGI2 (prostacyclin) in McN3716-treated rats. Similarly, the brain level of hydroxyeicosapentaenoic acids, nonenzymatic auto-oxidative metabolites of EPA, is reduced by 35% to 76% upon McN3716 treatment relative to vehicle.
-
体外实验——
-
体内实验Inhibition of brain mitochondrial β-oxidation by McN3716 (Methyl palmoxirate, MEP) significantly reduces the levels of all measured HETE and epoxytrienoic acids (EET), nonenzymatic auto-oxidative metabolites of ARA, by 23% to 44% and 32% to 50% compared with vehicle-injected rats, respectively, except for 15-HETE which was unaffected. There is a significant 34% reduction in the level of 6-keto-PGF1α, a byproduct of PGI2 (prostacyclin) in McN3716-treated rats. Similarly, the brain level of hydroxyeicosapentaenoic acids, nonenzymatic auto-oxidative metabolites of EPA, is reduced by 35% to 76% upon McN3716 treatment relative to vehicle.
-
同义词Methyl palmoxirate | NSC359682
-
通路Others
-
靶点Other Targets
-
受体Carnitine palmitoyltransferase I (CPT-1)
-
研究领域——
-
适应症——
化学信息
-
CAS Number69207-52-9
-
分子量298.46
-
分子式C??H??O?
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(C1(CCCCCCCCCCCCCC)OC1)OC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Chen CT, et al. Inhibiting mitochondrial β-oxidation selectively reduces levels of nonenzymatic oxidative polyunsaturated fatty acid metabolites in the brain. J Cereb Blood Flow Metab. 2014 Mar;34(3):376-9.
产品手册
关联产品
-
BDS I
Potent and reversible Kv3.4 potassium channel blocker (IC50 = 47 nM); also attenuates inactivation of sodium currents by acting on Nav1.7 and Nav1.3 channels. Enhances TTX-sensitive sodium currents in rat small dorsal root ganglion neurons. Neuroprotective.
-
IMT1B
IMT1B 是一种口服活性、非竞争性、特异性线粒体 RNA 聚合酶 (POLRMT) 变构抑制剂,可抑制线粒体 DNA (mtDNA) 表达。
-
Ac-Phe-NH2
Ac-Phe-NH2 是多聚泛素链延长的非竞争性抑制剂,Ki 值为 8 ± 1.2 mM。